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Abstract
Background: Exposure to genotoxic stresses such as radiation and tobacco smoke can cause increased cancer 
incidence rate as reflected in an in depth meta-analysis of data for women and breast cancer incidence. Published 
reports have indicated that exposures to low dose radiation and tobacco smoke are factors that contribute to the 
development of breast cancer. However, there is a scarcity of information on the combinatorial effects of low dose 
radiation and tobacco smoke on formation and progression of breast cancer. The combination of these two genotoxic 
insults can induce significant damage to the genetic material of the cells resulting in neoplastic transformation.
Methods: To study the effects of low dose ionizing radiation and tobacco smoke on breast cells, MCF 10A cells were 
treated either with radiation (Rad - 0.1 Gray) or cigarette smoke condensate (Csc - 10 microgram/ml of medium) or a 
combination of Rad + Csc. Following treatments, cells were analyzed for cell cycle distribution patterns and the ability 
to extrude the Hoechst 33342 dye. In addition, in vitro invasion and migration as well as mammosphere formation 
assays were performed. Finally, differential gene expression profiles were generated from the individual and 
combination treatment.
Results: Exposure of MCF 10A cells to the combination of radiation plus cigarette smoke condensate generated a 
neoplastic phenotype. The transformed phenotype promoted increased mammosphere numbers, altered cell cycle 
phases with a doubling of the population in S phase, and increased invasion and motility. Also, exclusion of Hoechst 
33342 dye, a surrogate marker for increased ABC transporters, was observed, which indicates a possible increase in 
drug resistance. In addition, changes in gene expression include the up regulation of genes encoding proteins 
involved in metabolic pathways and inflammation.
Conclusions: The results indicate that when normal breast cells are exposed to low dose radiation in combination with 
cigarette smoke condensate a phenotype is generated that exhibits traits indicative of neoplastic transformation. More 
importantly, this is the first study to provide a new insight into a possible etiology for breast cancer formation in 
individuals exposed to low dose radiation and tobacco smoke.
Background
Women who are exposed to genotoxic stresses such as
radiation and tobacco smoke have increased cancer inci-
dence rate as reflected in an in depth meta-analysis of
data for cancer incidence [1-5]. In particular, flight atten-
dants exhibit an increased risk of breast and acute myel-
oid leukemia cancers [1] as they are exposed to long-term
doses of low-frequency electromagnetic fields [2-4]. It is
well established that doses of low energy radiation can
induce double stranded DNA breaks that result in altered
gene expression profiles in mammalian cells, which are
transmitted to later generations of progeny cells [6]. This
lateral transfer of aberrant genomic damage can acceler-
ate the DNA damage rate in subsequent generations,
which has been referred to as a radiation induced
bystander effect [7,8]. Low dose ionizing radiation has
also been shown to alter the intracellular production of
reactive oxygen species (ROS), such as, hydrogen perox-
ide, superoxide anion and hydroxyl radicals [9], which
induce mutations and chromosomal aberrations in cells
[10]. These types of genetic alterations can promote
many pathological conditions including those associated
with aging and cancer [11,12]. Such radiation also can
dysregulate the expression of stress related proteins and
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oncoproteins. For example, a number of cellular proteins
such as transcription factors (c-Jun, c-fos, IL1, egr-1), cell
cycle control (p53, cyclin A and B), and DNA metaboliz-
ing proteins (PCNA, β polymerase, PARP) have been
shown to be elevated following low dose irradiation [13-
17]. Hence, it can be inferred that long term exposure to
low dose ionizing radiation can initiate the carcinogene-
sis process [18].
Besides low dose radiation, there is also a growing body
of evidence supporting the hypothesis that exposure to
tobacco smoke is a contributing factor in neoplastic
transformation of breast cells [5]. Environmental tobacco
smoke has been shown to contain high amounts of poly-
c y c l i c  a r o m a t i c  h y d r o c a r b o n s  ( P A H s )  m a n y  o f  w h i c h
have been shown to be potent carcinogens [19-21]. In a
rat model, exposure to PAHs rapidly induced palpable
mammary tumors [22]. Histological analysis revealed a
high incidence of adenocarcinoma indicating the potent
carcinogenic property of PAHs. In addition, exposure of
human mammary epithelial cells (HMECs) and breast
cancer cell lines to an activated PAH: racemic anti-3,4-
dihydroxy-1,2-epoxy-1,2,3,4 tetrahydrobenzo phenan-
threne (BPDE), found in active and passive cigarette
smoke, exhibited altered cell cycle progression, decreased
BRCA-1 expression, an increased a spectrum of p53
mutations [23-26] and neoplastic transformation [5].
Additionally, BRCA1 and BRCA2 mutational carriers,
who are also smokers, are at an increased risk of getting
breast cancer [27]. In contrary, there is evidence to indi-
cate that active smoke does not increase risk of breast
cancer in a cohort Japanese women [28].
The combined effect of long-term human exposure to
cigarette smoke in combination with ionizing radiation is
not known. Thus, the purpose of this research was to
determine the combined effects of radiation and cigarette
smoke on the ontogeny of breast cancer formation and
progression. Towards this goal, we have found that expo-
sure of non-tumorigenic immortalized MCF 10A breast
cells to low dose radiation and cigarette smoke conden-
sate promoted a transformed phenotype. These results
provide a new insight into a possible etiology for breast
cancer formation in populations such as medical staff,
aircrews, nuclear test participants and nuclear industry
workers that are exposed to low dose radiation and simul-
taneously may have the likelihood to be exposed to active
and second hand cigarette smoke.
Methods
Cell culture and exposure to radiation and cigarette smoke 
condensate
MCF 10A cells (ATCC, Rockville, MD) were irradiated at
0.67 cGy/min to the desired dose (0.1 Gy) using a γ-cell
40 137Cesium irradiator (Atomic Energy of Canada). A 40
mg/ml stock solution of cigarette smoke condensate
(Murthy Pharmaceuticals, USA) was prepared in DMSO
and diluted with culture medium to a final concentration
of 10 mg/ml. Exponentially growing cells were first irradi-
ated and then exposed to Csc (10 μg/ml) for 72 hr [29].
Flow cytometry and immunoblot analysis
Determination of DNA content by flow cytometry was
performed as previously described [30]. Briefly, 2 × 106
MCF 10A cells were incubated for 72 hr following indi-
vidual and combined treatments. Fixed cells were incu-
bated with a staining solution containing 0.56% NP-40,
3.7% formaldehyde, and 0.01 mg/ml Hoechst 33258 in
phosphate-citrate buffered (pH 7.2) solution. DNA con-
t e n t  w a s  a n a l y z e d  b y  f l o w  c y t o m e t r y  i n s t r u m e n t a t i o n
(BD Biosciences, San Jose, CA).
F o r  i m m u n o b l o t  e x p e r i m e n t s ,  2 0  μ g  o f  t o t a l  c e l l u l a r
protein was subjected to SDS-PAGE. Membranes were
probed with the primary antibodies indicated in the fig-
ure legend.
Invasion and wound healing
Matrigel (100 μl; 7-8 mg/ml) in serum-free medium was
added to each well of a Transwell Corning Costar plate
(Costar, Acton, MA, USA) and dried overnight in a tissue
culture hood. The following day, 2.5 × 104 cells in serum-
free medium were pipetted onto the Matrigel and com-
plete medium was added to the bottom trough. Following
incubation, the transmembrane filter was stained with
crystal violet and the number of cells counted.
For wound healing, a small area was cleared along a
diameter of the 10 cm dishes of confluent monolayers of
MCF 10A and MCF 10A treated cells with a sterile
pipette tip. Cell migration was measured and photo-
graphed from the wound/scratch edge every 8 hr.
Hoechst 33342 dye exclusion assay
Following treatments, cells were incubated in 0.01 mg/ml
of Hoechst 33242 dye for 45 minutes and then washed
and incubated for a further 45 minutes and photographed
using the Nikon 80i fluorescent microscope. Fluores-
cence intensity per cell (blue channel) was analyzed using
image J software (n = 4 in each case).
Affymetrix analysis
RNA was extracted using the Qiagen mRNA extraction
kit. The RNA samples were analyzed with Affymetrix
GeneChip Human 133 2.0 Arrays. The quality of the
microarray experiments was assessed with affyPLM and
Affy, found at Bioconductor http://www.bioconduc-
tor.org. All computation was performed under R environ-
ment http://www.r-project.org. The Affy  software was
used to estimate the gene expression signals and evalu-
ated using the Robust Multi-array Average [31]. Data nor-
malization was performed using a Bayes method at
Bioconductor, which includes log normal modeling.Botlagunta et al. BMC Cancer 2010, 10:343
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EBarrays was used to estimate the posterior probabilities
of the differential expression of genes between the control
and treated sample [32,33]. This data has been deposited
with Gene Expression Omnibus (GEO-accession number
GSE21066).
Generation of mammospheres
Single cell suspensions (total 5000 cells in 2 ml) in Dul-
becco's modified Eagle's medium/F-12 containing 5 mg/
mL insulin, 0.5 mg/mL hydrocortisone, 2% B27 (Invitro-
gen Ltd., Paisley, Scotland), and 20 ng/mL epidermal
growth factor were seeded into ultra-low attachment
plates (Corning, Lowell, MA) and incubated for 7-10 days
in presence of 20% O2 and 5% CO2 at 37°C. Subsequently,
the number of mammospheres formed were counted
using a microscope.
Results
Effects of low dose ionizing radiation and cigarette smoke 
condensate on MCF 10A cells
The effect of low dose ionizing radiation and cigarette
smoke condensate was tested using MCF 10A normal
immortalized breast cells. Following treatments, we
observed differences between the morphological appear-
ances of the differently treated cultures. Single treatment
regimes generated consistent changes in cellular mor-
phologies relative to the untreated controls (Figure 1A).
Thus, irradiation or Csc treatment resulted in popula-
tions of cells with a rounded or slightly elongated mor-
phology (Figure 1A top right and lower left panels). In
contrast, combined treatment (Rad + Csc) of MCF 10A
cells generated a phenotype that was somewhat fibro-
blast-like (Figure 1A lower right panel), which grew with
fewer cell to cell contacts and was less cuboidal than the
parental cells. Flow cytometry analyses were performed
to evaluate whether the latter phenotypic changes could
be associated with a change in cell growth rate or cell
cycle frequency and hence a change in proliferation rate.
As shown in Figure 1B, irradiation (0.1 Gray) increased
the percentage of cells found in G2/M from the 3.7%
found in the untreated cells to 39.2% while Csc treatment
increased the percentage of cells in G0/G1 from 49%
found in untreated cells to 75.4%. Thus, irradiation did
not cause G1 arrest for MCF 10A cells while Csc treat-
ment caused G1 arrest. However, treatment of MCF 10A
cells with a combination of radiation plus Csc resulted in
42.9% of the cells being in S phase, which is roughly dou-
ble that of the untreated cells and provides an indication
that the combined treatment increased the percentage of
proliferating cells (Figure 1B). Subsequently, immunoblot
analyses were performed to investigate whether the cell
cycle changes mediated by genotoxic stress could be cor-
related to the expression of cell cycle regulatory proteins.
As indicated in Figure 1C, p53 protein levels were slightly
increased following low dose irradiation, which was
matched to an increase in the levels of its downstream
target p21. In contrast to Rad, Csc or a combination of
radiation plus Csc treatment resulted in a down regula-
tion of p53 and p21 levels (Figure 1C). This indicates that
Figure 1 Phenotypic characterization and cell cycle analyses of MCF 10A cells treated with radiation and cigarette smoke condensate. Pan-
el A - Photomicrographs of MCF 10A-Rad + Csc treated cells (elongated) as compared to the parental MCF 10A cells (cuboidal). Panel B - Shows the 
percentage of cells distributed at the different phases of the cell cycle. Panel C - Immunoblot analyses of cell extracts from the control and treated 
MCF 10A cells. Primary antibodies were against p53 (Santa Cruz) and p21 (Cell Signaling). β-actin (Sigma) was scored for loading control.
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Rad + Csc can alter the levels of regulatory molecules to
dysregulate phases of the cell cycle.
Migration and invasive capabilities of treated MCF 10A cells
Increased cell motility and invasion are characteristics of
a neoplastic transformation. To test whether the geno-
toxic stresses used in our experimental setting could
increase the migration of MCF 10A cells, we used a
scratch/wound assay. As shown in Figure 2A, MCF 10A
cells treated with Rad as well as Rad + Csc were able to
migrate into the cleared area within 24 hr of incubation.
On the other hand, untreated and Csc treated MCF 10A
cells showed little migration into the cleared region dur-
ing this time period. W e next investigated the effect of
radiation and Csc on cell invasion in a modified Boyden
chamber assay. As depicted in Figure 2B, MCF 10 A cells
treated with Csc lack the ability to invade whereas Rad or
the combination Rad + Csc cells were extremely invasive
(four fold increase) as compared to the untreated and Csc
treated MCF 10A cells. Taken together these data indi-
cate that the Rad as well as Rad + Csc treated cells
acquired genetic/biochemical alterations that increased
the cells ability to migrate and invade, i.e., a possible
increase in dissemination or metastatic potential.
MCF 10A treated cells exhibit increase efflux of Hoechst 
33342 dye
A distinct characteristic of a metastatic phenotype is gen-
erally increased drug resistant properties. Some of the
pathways that promote drug resistance are elevated
expression of ATP-binding cassette (ABC) glycoprotein
transporters at the cell surface [34]. The elevated expres-
sion of these transporters can exclude vital dyes such as
Hoechst 33342 analogues to chemotherapeutic drugs,
thus promoting multi-drug resistance. As MCF 10A cells
treated with Rad + Csc induced a transformed pheno-
type, we evaluated the ability of these cells to extrude the
Hoechst 33342 dye, a surrogate marker for drug uptake.
As seen in Figure 2C &2D, cells treated with both Rad +
Csc retained less dye as compared to the untreated MCF
Figure 2 Invasion and wound healing assays of the treated MCF 10A cells. Panel A - In vitro wound healing assay. A filling of the cleared area, as 
demarcated by the horizontal red lines, was followed microscopically at 20× magnification. Panel B - Bar graph quantifying invasion of treated and 
untreated MCF 10A cells using Boyden chambers (means, n = 2). Panel C - Efflux of Hoechst 33342 in MCF 10A treated cells. Inset shows 40× magni-
fication of representative cells. Panel D - Bar graph showing quantification of the fluorescence intensity per cell in the blue channel.
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10A cells. This indicates that the combination treatment
in MCF 10A cells can induce a drug resistant phenotype.
Changes in gene expression profile and mammosphere 
formation following genotoxic stress
In an effort to determine which genes might be contribut-
ing to the increased cell invasion and migration capabili-
ties of Rad or Rad + Csc treated MCF 10A cells, we
performed expression analyses using the Affymetrix plat-
form. To identify differentially expressed gene sets fol-
lowing treatment, we compared the individual (Rad or
Csc) treatment data sets with the combined treatment
(Rad + Csc) data set using a Venn diagram (Figure 3A).
The Venn diagram indicates that 53 genes differentially
expressed in the combination treated cells compared to
untreated cells. Among these, 18 genes (12 up regulated
and 6 down regulated) have been reported as participat-
ing in cellular pathways of cancer (Figure 3B). Included in
this group were genes involved in tissue remodeling,
metabolism and cell adhesion molecules. One cell adhe-
sion molecule identified was CD44, which has been
directly correlated to human breast cancer grade [35].
Moreover, a high CD44 low CD24 expression profile in
breast cancer cell lines has been associated with a puta-
tive breast cancer initiating cell phenotype [36]. In order
to validate the microarray data, we estimated the CD44
levels in treated versus untreated cell lines. The expres-
sion level of CD44 was up regulated 2 fold in the com-
bined treatment as compared to the untreated and Rad
treated (Figure 3C). Recently, cells exhibiting a high CD44
low CD24 expression profile have been shown to form
mammospheres in culture conditions, which were resis-
tant to chemotherapeutic regimes [37]. Therefore, we
investigated the effect of genotoxic stress on MCF 10A
cells to form mammospheres in vitro. Figure 4A shows
representative mammosphere images under different
genotoxic stress. The combined treated cells formed the
most number of mammospheres as compared to individ-
ual treatments (Figure 4B). Thus, the Affymetrix data
indicates that the combined treatment can initiate gene
expression patterns that are associated with known can-
cers. That along with enhanced mammosphere formation
Figure 3 Differential gene expression pattern in MCF 10A cells following genotoxic stress. Panel A - Venn diagram depicting the total number 
of genes that intersect following exposure of MCF 10 A cells to Rad, Csc and Rad + Csc. Panel B - Select set of up and down regulated genes, at 72 hr 
following treatment, that intersect in Rad + Csc conditions. Panel C - CD44 and CD24 levels as determined by the real time PCR from RNA samples 
extracted from cell lines following Rad, Csc and Rad + Csc treatment.
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strengthens our suggestion that further experiments will
indicate that the altered gene profiles are consistent rep-
resentations of known cancer cell phenotypes.
Discussion
Long-term exposure to low dose radiation at levels that
can damage normal cell functions and propagate dsyreg-
ulated molecular programs can generate diseased tissue.
For example, aircrews, medical staff and workers in the
nuclear energy industry are often exposed to low dose
radiation as well as cigarette smoke and the combined
effect of these two environmental stresses likely identifies
these as a few of the populations that have an increased
risk of developing cancer. As low dose radiation and ciga-
rette smoke exposure may very well alter the breast tissue
biochemistry, physiology, and morphology, it is essential
to determine if the combined effects of such exposures
induces genetic/biochemical alterations that can trigger
breast tumor formation. Such considerations led us to
study the action of the combined environmental geno-
toxic stresses of low dose radiation and cigarette smoke
condensate on immortalized non-tumorigenic breast epi-
thelial cells, MCF 10A. The finding that exposing cells to
both Rad + Csc generated cells that exhibited a fibroblas-
tic phenotype, which is different from the normal cuboi-
dal shaped MCF 10A cells, is a clear indication that
fundamental genetic alterations occurred during treat-
ment. The low dose irradiation used in this study induced
cell cycle arrest (G2/M), which is in agreement with this
well known effect occurring in cells exposed to radiation
[38]. Although, we observed only marginal increases in
p53 and p21, these changes nevertheless support the
known function of these proteins in this check point pro-
cess [39]. However, Csc and combined treated cells
reversed or abrogated the check point response to ioniz-
ing radiation and caused a shift in cell cycle to G0/G1 and
S phase respectively with concomitant decreases in p53
and p21. The alterations in the cell cycle distribution pat-
tern following combined treatment indicates that a com-
bination of genotoxic exposures is more detrimental with
respect to the generation of a proliferating phenotype
then either single exposure under the conditions used
here.
Tumorigenesis is a complex process and it involves
intricate biological mechanisms such as invasion and
motility that are essential attributes of metastasis [40].
We observed that Rad or Rad + Csc doubled the percent-
age of cells that invaded the Matrigel. We have further
demonstrated that exposure of MCF 10A cells to low
dose radiation followed by Csc altered the transcription
profiles of a number of genes that fell into two broad cate-
gories: (1) those with common responses across individ-
ual treatments and (2) those with differential responses
associated with combined treatment. Our study is the
first genome-wide analysis of transcript profiles associ-
ated with concomitant radiation and cigarette smoke
condensate exposures. The major changes associated
with the differential response can be categorized as those
c e l l u l a r  p r o p e r t i e s  a s s o c i a t e d  w i t h  t i s s u e  r e m o d e l i n g ,
metabolism, and altered cell membrane protein levels,
while a more ambiguous outcome was observed for genes
involved in inflammation and signaling events. Our find-
ings of increased transcript levels in a large number of
metabolic genes appear to indicate that metabolism is an
important component of stress response mechanisms
after exposure to radiation or Csc. An increase in Cyto-
chrome P450 observed in Rad + Csc treated cells may
metabolically activate the carcinogens present in ciga-
Figure 4 Mammosphere formation of MCF 10A cells treated with radiation and cigarette smoke condensate. Panel A - Photomicrographs of 
the mammospheres following treatment with Rad, Csc and Rad + Csc. Panel B - Shows the total number of mammospheres following exposure to 
Rad, Csc and Rad + Csc. The counts represented are averages from two independent experiments.
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rette smoke within the breast environment to promote
carcinogenesis. Furthermore, cell membrane proteins
have been previously reported to be elevated after low
dose radiation exposures [41]. The significant changes in
the expression level of CD44 and mammosphere number
induced by Rad + Csc supports the generation of radio-
resistant phenotype as compared to individual treated
fraction [37].
Although a direct correlation of results obtained on
cultured human cells to the human situation requires
additional research, we envisage that the results of the
present study will help initiate further studies on the
affects of long term human exposure to low dose radia-
tion and tobacco smoke in the pathogenesis of breast can-
cer.
Conclusions
In conclusion, we have demonstrated that short term
exposure of normal breast cells to low doses of ionizing
radiation and the potent carcinogens in tobacco smoke
condensate can induce genetic and phenotypic changes
that reflect those of known cancer cell types. Given the
limitations of these in vitro studies and the complexities
of translating these findings to real life responses to such
environmental mutagens and carcinogens is a strong
indication that further investigation will be required to
conclusively demonstrate the risk of getting breast cancer
following exposure to low dose radiation and cigarette
smoke. Still this is the first study to demonstrate the
effects of low dose ionizing radiation in combination with
exposures to tobacco smoke carcinogens that can result
in a possible initiation of cellular processes that give rise
to breast cancer cells.
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